Stories

Discover all of the trending stories of Ipsen Group.

Key highlights

Explore more by category

Filter

Period

Filter by

recent search

Sort

Showing: 1 – 10 of 45 stories

Statement on lanreotide European decentralised procedure
 –  – 1 mins read

 – 1 mins read

Statement on lanreotide European decentralised procedure

PARIS, FRANCE, 8 March 2021 – Ipsen has learned that Amdipharm Ltd, which is believed to be a subsidiary of Advanz Pharma, has received a positive outcome by the Reference Member State, Denmark, and closure of the Decentralised Procedure, for a generic f


Ipsen announces the arrival of Gwenan White, EVP Communications & Public Affairs
 –  – 1 mins read

 – 1 mins read

Ipsen announces the arrival of Gwenan White, EVP Communications & Public Affairs

We are pleased to announce the arrival of Gwenan White as Executive Vice President, Communications and Public Affairs, effective 1 March 2021. Based in Boulogne, France, she will be responsible for designing, implementing and managing the communications an


Ipsen and the fight against corruption
 –  – 1 mins read

 – 1 mins read

Ipsen and the fight against corruption

Today is International Anti-Corruption Day. We are all aware that corruption has the potential to impact the social and economic development of all companies, societies and countries. That is why we must be unified in our efforts to conduct business with t


Ipsen’s new strategic priorities unveiled at virtual Capital Markets Day event
 –  – 2 mins read

 – 2 mins read

Ipsen’s new strategic priorities unveiled at virtual Capital Markets Day event

Today, Ipsen is hosting a virtual Capital Markets Day to launch our new Group strategy which positions us for long-term success by focusing together for patients and society. Four priorities will drive continued growth and bring transformative medicines to


Ipsen – Capital Markets Day Webcast – Tuesday, December 1, 2020
 –  – 1 mins read

 – 1 mins read

Ipsen – Capital Markets Day Webcast – Tuesday, December 1, 2020

David Loew, Chief Executive Officer, is pleased to host a Capital Markets Day webcast to present the Group’s Strategy on:


1 5 6 7 8 9

Discover trending stories

02 June 2023 1 mins read
Ipsen’s partnership with Marengo

Find out more about how we approach partnerships at Ipsen, where every program is a priority within our pipeline. We sat down with Zhen Su, CEO Marengo, to discuss our partnership and how we undertake a one team approach to accelerate innovation for the pa

01 June 2023 1 mins read
Ipsen’s 2022 Integrated Annual Report now available

2022 was a year of focus, momentum and growth at Ipsen. Learn about the progress we made and download the 2022 Integrated Annual Report here.

31 May 2023 1 mins read
Collette: finding community through PBC

Collette spent almost 20 years going back and forth between different doctors and treatments, before she was finally diagnosed with PBC.

31 May 2023 1 mins read
Caitlin: learning to accept care as a caregiver

In September 2012, when she was 21, Caitlin received news every child dreads: her father had been diagnosed with pancreatic cancer and had been given three months to live.

31 May 2023 1 mins read
Steve: taking action against kidney cancer

Steve has been diagnosed with kidney cancer twice. After initial success with a nephrectomy, his cancer returned in January 2018. This time, his doctor said there was no treatment available. “He advised I would probably be put on life-extending drugs,”

31 May 2023 1 mins read
Diana: Taking spasticity in stride   

Diana was a full-time journalist when, at the age of 34, she experienced a stroke that impacted her movement and left her with spasticity.

23 May 2023 1 mins read
Fireside Chat: Innovation and Policy Change in Rare Diseases

The rare disease community continues to strive for innovative solutions to meet patient needs and ensure no person living with a rare disease is left behind.  

23 May 2023 2 mins read
Applications now open for the 2023 Golden Ticket Competition

As part of our commitment to accelerating transformative research and development, we’re excited to announce that our Golden Ticket Competition is now open! Through our continued partnership with Biolabs, we’re delighted to be offering the brightest mi

12 May 2023 4 mins read
Understanding the true impact of living with FOP

This year marks the 17th anniversary since the discovery of the ACVR1 gene was announced, a major scientific milestone in fibrodysplasia ossificans progressiva (FOP) research that helped us understand what causes the condition. On April 23,

02 March 2023 1 mins read
Rethinking risk factors this Liver Cancer Awareness Month

Learn how to engage with our campaign and help protect your liver health. Every year, Liver Cancer Awareness Month (LCAM) is an opportunity to bring the sixth most prevalent cancer globally to the forefront of conversation, promoting awareness and the impo